Red-Hot Biotechs to Take Spotlight at Blood Disorder Meeting

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Dec 4, 2020 at 11:33 AM.

  1. #1 cafead, Dec 4, 2020 at 11:33 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,979
    Likes Received:
    3
    via High-flying drug developers that have surged in the face of the ongoing coronavirus pandemic will be in focus starting this weekend at the year’s last big medical meeting, putting surging stocks under the microscope for investors who have cheered massive gains.

    Updated results from Trillium Therapeutics Inc., which has boomed 1,550% this year, will be among those most closely watched by Wall Street at the American Society of Hematology (ASH) meeting that kicks off Saturday.

    article source
     
    Quote

Reply to Thread